News | November 06, 2006

FDA Clearance Expanded for Stereotaxis

Stereotaxis has received FDA 510(k) clearance for its Niobe magnetic navigation system for use in neurovascular and peripheral applications with the company's family of Cronus magnetically enabled .014" vascular guide wires. The Niobe System and Cronus guide wires were previously cleared for coronary vasculature procedures only.

The Cronus guide wire family will now integrate with the Niobe magnetic navigation system to provide precise magnetic guide wire navigation in coronary, neurovascular and peripheral anatomy, according to a company press statement.

"While we have no current plans to immediately move into peripheral and neurovascular clinical applications, this clearance provides us with the flexibility to do so at a time of our choosing," said Bevil Hogg, President and Chief Executive Officer of Stereotaxis, Inc. "We believe this latest clearance is further evidence of the broad applicability of our system to the entire body."

Related Content

Transesophageal Echo, TEE. Interventional echocardiography, interventional echo, Philips, CX50

Transesophageal echo (TEE) has become an essential part of the new transcatheter structrual heart therapies, giving rise to a new sub-speciality of interventional echocardiography.  

Feature | Cath Lab Navigation Aids | September 21, 2016 | Dave Fornell
The rapid growth of transcatheter structural heart procedures and the need for increased use of echocardiography as a
News | Cath Lab Navigation Aids | January 15, 2016
Teleflex Inc. has acquired privately held Nostix LLC, developer of innovative tip confirmation systems that are used to...
vessel assist, CTO fusion imaging

An example of Vessel Assist used to create vessel centerlines through a CTO to help guide revascularization in the cath lab.

Technology | Cath Lab Navigation Aids | December 14, 2015
December 14, 2015 — As the field of interventional medicine grows, so do the challenges for clinicians to plan, guide
Overlay Init